T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 3,204,964 shares of Anterix Inc. common stock as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: T. Rowe Price Investment Management, Inc. reported beneficial ownership of 3,204,964 shares of Anterix Inc. common stock.
- Percent of class: The reported holdings represent 16.3% of the class of securities, according to the filing.
- Sole voting power: The filing disclosed sole voting power over 3,203,105 shares, with no shared voting power reported.
- Sole dispositive power: Sole power to dispose of or direct the disposition of 3,204,964 shares was reported, with no shared dispositive power.
- T. Rowe Price Small-Cap Stock Fund interest: T. Rowe Price Small-Cap Stock Fund holds an interest in 1,055,994 of the reported shares, representing 5.6% of the class, according to the filing.
- Event date: The date of the event requiring the filing was stated as September 30, 2026.
T. Rowe Price Investment Management Discloses Amended Ownership Position in Anterix
T. Rowe Price Investment Management, Inc., a Maryland-incorporated investment adviser, filed Amendment No. 1 to Schedule 13G with the SEC on November 16, 2026, covering its holdings in Anterix Inc. (NASDAQ:ATEX), a company headquartered at 3 Garret Mountain Plaza, Suite 401, Woodland Park, NJ 07424. The filing was triggered by an event dated September 30, 2026, and covers shares of Anterix common stock with CUSIP number 03676C100.
According to the filing, T. Rowe Price Investment Management holds an aggregate of 3,204,964 shares, equating to 16.3% of the outstanding class. The firm reported sole voting power over 3,203,105 shares and sole dispositive power over the full 3,204,964 shares. No shared voting or dispositive power was reported. The filing identified T. Rowe Price Investment Management as an investment adviser, and its principal business office is located at 1307 Point Street, Baltimore, MD 21231.
The filing disclosed that T. Rowe Price Small-Cap Stock Fund, for which T. Rowe Price Investment Management serves as investment adviser, holds an interest in 1,055,994 shares of the reported class, representing 5.6% of the class. The filing further stated that ultimate power to direct receipt of dividends and sale proceeds "is vested in the individual and institutional clients which Price Investment Management serves as investment adviser," and that "any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time." The filing was signed by Ellen York, Vice President of T. Rowe Price Investment Management, Inc., on November 16, 2026.
What Was Disclosed
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 3,204,964 shares, or 16.3%, of Anterix Inc. common stock as of September 30, 2026, including an identified 1,055,994-share interest held through T. Rowe Price Small-Cap Stock Fund.



Please wait processing your request...